Hong Kong Aerospace & Defense Stock News

COSCO SHIPPING Energy Transportation reported half year 2026 results with revenue of CNY 15,146.1 million and net income of CNY 4,545 million, alongside an interim dividend of CNY 0.28 per share, with ex dividend, record, and payment dates set in September and October 2026. Across the same period, basic earnings per share from continuing operations reached CNY 0.8315 compared with CNY 0.3917 a year earlier, indicating a significantly higher profit level that aligns with the decision to...

Robosense Technology’s interim update and robotics push Robosense Technology (SEHK:2498) has released its 2026 interim update, pairing LiDAR platform progress with a clear push into broader robotics hardware. The stock move now sits alongside a detailed product and commercialization roadmap. The interim update lands after a weak run for Robosense Technology’s shares, with the 30-day share price return down 24.75% and the year-to-date share price return down 51.98%, while the 1-year total...

Bank of China completed multiple CNY 20b bond offerings in 2026, including fixed rate callable bonds due 2030 and 2032, and floating rate green notes due 2029. The bank also reported CNY 236,733m net interest income and CNY 123,594m net income for the first half and proposed an interim cash dividend. The mix of callable fixed income issuance, green financing support for Shenzhen’s offshore yuan bonds in Hong Kong, and an interim dividend reflects Bank of China’s focus on funding flexibility,...

Ubtech Robotics reported half-year 2026 results, with sales of CNY 1,269.13 million versus CNY 621.46 million a year earlier and a net loss of CNY 311.48 million compared with CNY 413.65 million previously. The business more than doubled sales while reducing both absolute net loss and loss per share, indicating changes in operating efficiency even as it continues to invest for scale in humanoid and service robotics. Next, the focus is on how Ubtech Robotics' revenue expansion alongside...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Kerry...

Some China XLX Fertiliser Ltd. ( HKG:1866 ) shareholders may be a little concerned to see that the Executive Director...

BOC Hong Kong (Holdings) reported half year 2026 net interest income of HK$28,182 million and net income of HK$23,739 million, alongside a special cash dividend of HK$0.2388 per share and a second interim dividend of HK$0.29 per share, both with an ex dividend date on 10 September 2026. The combination of higher half year earnings and two cash dividends points to management confidence in current profitability and cash generation. This matters for investors tracking dividend reliability and...

SUNeVision Holdings (SEHK:1686) is back in focus after reporting full year results that show higher sales and net income, along with a higher annual dividend, a combination that often sharpens attention on shareholder returns. The share price of SUNeVision Holdings is trading at HK$5.68 after a strong 30 day share price return of 15.92% and a 90 day gain of 9.44%. However, the 1 year total shareholder return is still down 13.89%, while the 3 year total shareholder return is up 79.49%. This...

PetroChina (SEHK:857) has highlighted income and earnings after reporting half-year results, along with an interim ordinary dividend of RMB 0.26 per share for the six months to June 30, 2026. Recent trading has been strong, with PetroChina’s share price up 3.3% over the past week and posting a 9.0% 1 month share price return, while the 1 year total shareholder return of 48.5% and 5 year total shareholder return above 3x indicate that momentum has been building around the story. Scan...

Fosun International reported H1 2026 revenue of CNY 86,963.36 million with net income of CNY 1,721.06 million, while its Hang Seng Sustainability Rating moved up to AA+ alongside fresh ESG index inclusions. The combination of stronger profitability and upgraded ESG recognition indicates that Fosun International is tightening execution while aligning its portfolio more closely with sustainability focused capital. The focus now turns to how Fosun International's AA+ sustainability rating...

Geely Automobile Holdings reported August 2026 sales of 270,194 units, up about 8% year on year, with Proton’s monthly and year-to-date volumes also rising strongly versus 2025. The right-hand-drive launch of Riddara RD6 models in Southern Africa underscores Geely Automobile Holdings’ push to scale new energy pickups beyond China. Now it is worth asking how this combination of stronger unit volumes and wider Riddara export reach could reshape Geely Automobile Holdings’ investment...

China Overseas Property Holdings (SEHK:2669) has been dropped from the Hang Seng China Affiliated Corporations Index, an adjustment that can reshape how index-tracking funds treat the stock and influence short term trading flows. At a share price of HK$3.545, China Overseas Property Holdings has seen a 1-month share price return of 4.26% and a 7-day gain of 2.60%. However, the 1-year total shareholder return is down 29.48% and the 3-year total shareholder return has fallen 57.68%, which...

China Everbright Environment Group reported half year 2026 results with sales of HK$14,181.32 million and net income of HK$2,431.24 million, and announced an interim dividend of HK$0.16 per share with an ex dividend date of 21 September 2026 and payment on 20 October 2026. Net income and basic earnings per share from continuing operations both came in higher than the prior year period, which points to tighter execution across the business despite broadly similar revenue. With earnings per...

Beijing Enterprises Water Group Limited announced an interim ordinary cash dividend of HK$0.0554 per share for the six months ended 30 June 2026, with the record date on 10 September 2026 and payment scheduled for 26 October 2026. The lower interim dividend indicates that Beijing Enterprises Water Group may be prioritising balance sheet resilience or funding needs over near term cash returns to shareholders. The next step is to consider how this reduced interim dividend influences Beijing...

Sino Biopharmaceutical recently reported three key pipeline milestones, including positive preclinical data for oral STAT6 degrader TQH5528, FDA IND clearance for GPC3 ADC TQB6426 for advanced tumors, and encouraging Phase I results plus Lancet publication for Lp(a) lowering siRNA Kylo-11. These updates show Sino Biopharmaceutical spreading R&D risk across respiratory, oncology and cardiovascular programs, while moving from platform science into clinically validated, late preclinical and...

Shareholders in China Shenhua Energy Company Limited ( HKG:1088 ) may be thrilled to learn that the analysts have just...

Laopu Gold reported half year 2026 results with sales of CNY 19,808.37 million, net income of CNY 4,267.23 million, and basic EPS of CNY 24.16, and also declared an interim cash dividend of RMB 18.02 per share with payment scheduled for January 22, 2027. The combination of higher earnings per share from continuing operations and a sizable interim dividend suggests Laopu Gold is returning a significant share of recent profits directly to investors. Given this mix of stronger first half...

China Resources Power Holdings reported half year 2026 results with sales of HK$54,976.93 million, net income of HK$6,649.41 million and basic earnings per share of HK$1.28, alongside an interim dividend of HK$0.321 per share. The company coupled these financial updates with a broad reshuffle of independent directors and board committee roles, which may influence how China Resources Power Holdings balances sustainability oversight, remuneration decisions and risk governance going...

Rising odds of a Fed rate hike, gold holding near US$4,400, and fresh geopolitical risk in the Middle East are pulling money toward perceived havens and away from high-octane growth stories. That reshuffle creates both potential safety nets and potential traps. This piece walks through three precious metals stocks from our screener that appear especially exposed to these headlines, so you can decide which opportunities or risks deserve a closer look. The stocks covered below are just a small...

Kingboard Holdings stock reacts to higher interim dividend and half year results Kingboard Holdings (SEHK:148) has come into focus after reporting half year 2026 sales of HK$29,131.39 million and net income of HK$2,711.41 million, alongside declaring an interim dividend of HK$0.73 per share. At a latest share price of HK$52.35, Kingboard Holdings has seen mixed momentum, with a 1 day share price return of 4.18% and a 30 day share price return of 11.05%, while its 90 day share price return...

Why Jinhai Medical Technology’s Latest Half Year Results Matter Jinhai Medical Technology (SEHK:2225) has drawn fresh attention after reporting half year 2026 results. Sales reached SGD 34.02 million while the company reported a reduced net loss of SGD 4.36 million. For investors watching the stock in early September 2026, the combination of higher reported sales and a smaller loss compared with the prior year raises questions about how the business mix and cost base are evolving. Jinhai...

Why BYD Electronic (International) Stock Is Back in Focus BYD Electronic (International) (SEHK:285) is drawing fresh attention after its half year 2026 results showed sales of CNY 82,234.2 million, alongside a sharp drop in net income to CNY 426.33 million. The earnings announcement has arrived after a volatile stretch for BYD Electronic (International). The share price is up 6.84% on the day and has posted a 12.28% 1‑month share price return. However, it remains down 23.81% year to date and...

The renewed debate around Trump-era China tariffs is shining a light on where real capital is actually going. While some US industrials lean more on financial engineering, sections of China’s manufacturing base appear to stay closer to bricks, machines and factories. For investors, that opens up a fresh way to think about long-term exposure to industrial growth. This article walks through three Chinese manufacturing stocks that screen positively against this backdrop. The three stocks...

Akeso’s partner Summit Therapeutics reported that Akeso’s PD-1/VEGF bispecific ivonescimab achieved statistically significant overall survival gains over pembrolizumab and durvalumab in separate Phase III trials for PD-L1 positive non-small cell lung cancer and advanced biliary tract cancer, building on prior progression-free survival wins and recent China approvals. This string of head-to-head successes against current immunotherapy standards of care underscores ivonescimab’s potential to...